Mylan Urges Full Fed. Circ. To Ax Vanda Drug IP Under Mayo
Mylan Inc. urged the the full Federal Circuit to rehear a panel's split preservation of a patent covering Vanda Pharmaceuticals Inc.'s schizophrenia drug Fanapt, arguing Wednesday the patent claims don't meet...To view the full article, register now.
Already a subscriber? Click here to view full article